What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli.

Area of Science:

• Comparative infectious disease epidemiology
• Antimicrobial resistance (AMR) research
• Global health policy

Background:

• Dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram-negative bacilli (MDR GNB) present significant global health threats.
• Despite differing pathogenesis and epidemiology, these resistant pathogens exhibit striking similarities in their impact and spread.

Discussion:

• Examining successful and challenging strategies employed by the global TB community to combat MDR TB.
• Key strategies include promoting judicious anti-TB medication use, optimizing molecular diagnostic testing, fostering new antimicrobial agent development, and reinforcing surveillance and infection control.

Key Insights:

• Lessons learned from MDR TB control efforts are directly applicable to addressing the MDR GNB pandemic.
• A multifaceted approach encompassing diagnostics, therapeutics, surveillance, and infection control is crucial for both MDR TB and MDR GNB.

Outlook:

• Leveraging insights from MDR TB management can accelerate the development of effective control strategies for MDR GNB.
• Continued global collaboration and investment in research and public health infrastructure are essential for mitigating the threat of antimicrobial resistance.